As of the end of September 2023, PSI is 1,931 members strong, spanning across 53 countries and 5 continents. Approximately 42% of PSI’s members live outside of the UK, with the next largest contributors being Germany, Switzerland, and the United States.
As well as being geographically diverse, PSI’s members work for a host of different companies, with 32 of these having at least 5 full members. Thank you to all those companies that consistently support PSI’s mission. However, PSI is not exclusive to those working in the pharmaceutical industry. PSI’s membership base currently includes 358 students and teachers from schools and universities across the UK and beyond.
Many of these members had the opportunity to interact in-person at this year’s annual conference in London, which saw record-breaking attendance with 618 delegates listening to more than 120 speakers across 40 sessions.
In addition to in-person events, PSI endeavours to meet the needs of this diverse membership base by offering a range of virtual content, with the most attended live virtual event in the past year being the PSI EIWG webinar: “Proposing Estimands from Different Perspectives,” with ~460 attendees joining in March. Event attendance remained high throughout the year, with the most attended live virtual event of the past 3 months being the PSI webinar: “Application of Bayesian Methods in Confirmatory Trials” with ~340 attendees.
PSI also currently provides access to over 400 recorded trainings through its Video-on-demand service, 47 of which were added this year alone. While “Proposing Estimands from Different Perspectives,” also holds the title for the most-watched VoD of the past year, PSI’s Journal Club webinar: “Propensity Scores” is the most watched title added within the past 3 months.
PSI also engages with its members via social media platforms, including LinkedIn and X (formerly known as Twitter). At the end of September, the number of followers on each platform totalled 3,921 and 1,066, respectively.
As an engaged community of individuals from a range of different backgrounds and disciplines, PSI strives to deliver varied and accessible content to its ever-growing membership across the globe.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The book club’s usual focus is to read and discuss professional development books. In this short format event you can more easily develop you career without the commitment of reading the whole book - simply listen to the 1-hour long podcast before joining the interactive session on 21 May.
This webinar is organised by the RWD SIG and the Historical Data SIG. We will review recent methods, applications, and tools of integrating subject-level-data from clinical trial with external data using Bayesian methods and/or causal inference methods.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This will be a 45 minute webinar which will explain the topic presented in the published paper, ‘Applying the Estimand Framework to Clinical Pharmacology Trials with a Case Study in Bioequivalance’. There will be 15 minutes for a panel Q&A with some of the authors following the presentation.
This 1-hour webinar will be an opportunity to hear about the methodology and first results of the iRISE consortium. iRISE is working towards a better understanding of reproducibility and the interventions that work to improve it. At the end of the presentation there will also be the opportunity to ask questions.
This one-day event focuses on the comprehensive management of transitioning to R/Open-Source, addressing the challenges and providing actionable insights. Attendees will participate in sessions covering essential topics such as training best practices, creating strategic plans, making the case to senior management, and managing both statistical and programming aspects of the transition.
Develop your non-technical skills by reading The Art of Explanation by Ros Atkins and joining the Sept-Dec 2025 book club. You will be invited to join facilitated discussions of the concepts and ideas and apply skills from the book in-between sessions.
This course is aimed at biostatisticians with no or some pediatric drug development experience who are interested to further their understanding. We will give you an introduction to the pediatric drug development landscape. This will include identifying the key regulations and processes governing pediatric development, a discussion on the needs and challenges when conducting pediatric research and a focus on the ways to overcome these challenges from a statistical perspective.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
The program will feature insightful sessions led by distinguished invited speakers, alongside a poster session showcasing the latest advancements in the field. Further details will be provided.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
The Institute of Cancer Research are seeking to appoint a Research Group Leader to join The CRUK Clinical Trials and Statistics Unit at the ICR.
This is an exciting, new opportunity for an experienced Statistician looking to take the next step in their career. Offered as a remote or hybrid position aligned with our site in Harrogate, North Yorkshire.
